Adline Chem Lab Limited

KAMRLAB

INE276T01018

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:59 21/06/2024 BST			5-day change	1st Jan Change
13.25 ^INR	-0.60%		-0.82%	-50.54%

03-05	Adline Chem Lab CFO Steps Down	MT
03-05	Adline Chem Lab Limited Announces CFO Changes	CI

Kamron Laboratories Limited has Changed its Name to ADLINE CHEM LAB LIMITED

September 30, 2021 at 05:00 am

On September 30, 2021, Kamron Laboratories Limited changed its name to ADLINE CHEM LAB LIMITED.

Latest news about Adline Chem Lab Limited

Adline Chem Lab CFO Steps Down	03-05	MT
Adline Chem Lab Limited Announces CFO Changes	03-05	CI
Adline Chem Lab Limited Appoints Sarang Pathak as Managing Director	03-05	CI
Adline Chem Lab Limited Announces Resignation of Kamlesh Lashkari as Director	02-28	CI
Adline Chem Lab Appoints CFO	02-05	MT
Adline Chem Lab Limited Announces Management Changes	02-03	CI
Adline Chem Lab Limited Announces Chief Financial Officer Changes	02-03	CI
Adline Chem Lab Limited Announces Change of Registered Office Address	02-03	CI
Adline Chem Lab Limited Announces Resignation of Ms. Bhavasthi Mehta as Company Secretary and Compliance Officer	31/07/23	CI
Hemant Amrish Parikh entered into a share purchase agreement to acquire a 24.48% in Adline Chem Lab Limited from Kamlesh J. Laskari HUF, Ranak K. Laskari, Rohan K. Laskari and Sohan K. Laskari for INR 7.5 million.	17/05/23	CI
Hemant Amrish Parikh made an open offer to acquire a 26% stake in Adline Chem Lab Limited for INR 8 million.	17/05/23	CI
Kamron Laboratories : Changes Company Name to Adline Chem Lab	15/10/21	MT
Kamron Laboratories : Changes Name to Adline Chem Lab	14/10/21	MT
Kamron Laboratories Limited has Changed its Name to ADLINE CHEM LAB LIMITED	30/09/21	CI
Kamron Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021	14/08/21	CI
Kamron Laboratories Ltd Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2021	30/06/21	CI
Kamron Laboratories Ltd Announces Board Changes	09/04/21	CI
Kamron Laboratories Ltd Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020	13/02/21	CI
Kamron Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2020	22/09/20	CI
Kamron Laboratories Ltd Announces Earnings Results for the Year Ended March 31, 2020	31/08/20	CI
Kamron Laboratories Ltd Announces Standalone Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2019	14/02/20	CI
Kamron Laboratories Ltd Announces Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2019	14/11/19	CI
Kamron Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019	19/08/19	CI
Kamron Laboratories Ltd. Reports Unaudited Standalone Earnings for the Fourth Quarter and Year Ended March 31, 2019	10/06/19	CI
Kamron Laboratories Ltd Appoints Bhavasthi R. Mehta as Company Secretary and Compliance Officer	14/02/19	CI

Adline Chem Lab Limited, formerly Kamron Laboratories Limited, is an India-based pharmaceutical company. The Company is operating in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. The Company's products for the international market include tablets, capsules and injections. The Company's veterinary products include B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. The Companyâs educational supplements include Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat and Demo-Eose eryth.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ADLINE CHEM LAB LIMITED	-50.54%	927K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.50%	42.12B
OTSUKA HOLDINGS CO., LTD.	+20.78%	21.72B
SANDOZ GROUP AG	+21.14%	15.75B
CIPLA LIMITED	+23.69%	14.89B
ZYDUS LIFESCIENCES LIMITED	+57.44%	13.06B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-14.94%	6.3B
ASPEN PHARMACARE HOLDINGS LIMITED	+20.03%	6.05B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals

Adline Chem Lab Limited

Equities

KAMRLAB

INE276T01018

Pharmaceuticals

Kamron Laboratories Limited has Changed its Name to ADLINE CHEM LAB LIMITED

Latest news about Adline Chem Lab Limited

Chart Adline Chem Lab Limited

Company Profile

Sector Generic Pharmaceuticals